Freeman, G., et al., "B7, a new Member of the Ig Superfamily with Unique Expression on Activated and Neoplastic B Cells," The Journal of Immunology, vol. 143, No. 8, 2714-2722 (1989). |
Freeman, G., et al., "Cloning of B7-2; A CTLA-4 Counter-Receptor that Costimulates Human T Cell Proliferation," Science, vol. 262, 909-911 (1993). |
Freeman, G., et al., "Structure, Expression, and T Cell Costimulatory Activity of the Murine Homologue of the Human B Lymphocyte Activation Antigen B7," J. Exp. Med., vol. 174, 625-631 (1991). |
Galvin, F., et al., "Murine B7 Antigen Provides a Sufficient Costimulatory Signal for Antigen-specific and MHC-restricted T Cell Activation," The Journal of Immunology, vol. 149, No. 12, 3802-3808 (1992). |
Gimmi, C., et al., "B-cell Surface Antigen B7 Provides a Costimulatory Signal That Induces T Cells to Proliferate and Secrete Interleukin 2," Proc. Natl. Acad. Sci. USA, vol. 88, 6575-6579 (1991). |
Gimmi, C., et al., "Human T-cell Clonal Anergy is Induced by Antigen Presentation in the Absence of B7 Costimulation," Proc. Natl. Acad. Sci. USA, vol. 90, 6586-6590 (1993). |
Harding, F. and Allison, J., "CD28-B7 Interactions Allow the Induction of CD8.sup.+ Cytotoxic T Lymphocytes in the Absence of Exogeneous Help," J. Exp. Med., vol. 177, 1791-1796 (1993). |
Harding, F., et al., "CD28-medicated Signalling Co-stimulates Murine T Cells and Prevents Induction of Anergy in T-cell Clones," Nature, vol. 356, 607-609 (1992). |
James, R.F.L. et al., "The Effect of Class II Gene Transfection on the Tumourigenicity of the H-2K-negative Mouse Leukaemia Cell Line K36.16," Immunology, vol. 72, 213-218 (1991). |
Lenschow, D., et al., "Expression and Functional Significance of an Additional Ligand for CTLA-4," Proc. Natl. Acad. Sci. USA, vol. 90, 11054-11058 (1993). |
Linsley, P., et al., "Binding of the B Cell Activation Antigen B7 to CD28 Costimulates T Cell Proliferation and Interleukin 2 mRNA Accumulation," J. Exp. Med., vol. 173, 721-730 (1991). |
Nabavi, N., et al., "Signalling Through the MHC Class II Cytoplasmic Domain is Required for Antigen Presentation and Induces B7 Expression," Nature, vol. 360, 266-268 (1992). |
Ostrand-Rosenberg, S., et al., "Abrogation of Tumorigenicity by MHC Class II Antigen Expression Requires the Cytoplasmic Domain of the Class II Molecule," The Journal of Immunology, vol. 147, No. 7, 2419-2422 (1991). |
Ostrand-Rosenberg, S., et al., "Costimulation Through Murine B7 Molecule Restores Immunogenicity of Autologous Tumor Cells Expressing Truncated MHC Class II Molecules," J. Cell. Biochem., Supplement (Abstract HZ 228), 71 (1993). |
Ostrand-Rosenberg, S., et al., "Rejection of Mouse Sarcoma Cells After Transfection of MHC Class II Genes," The Journal of Immunology, vol. 144, No. 10, 4068-4071 (1990). |
Reiser, H., et al., "Murine B7 Antigen Provides an Effecient Costimulatory Signal for Activation of Murine T Lymphocytes Via the T-cell Receptor/CD3 Complex," Proc. Natl. Acad. Sci. USA, vol. 89, 271-275 (1992). |
Baskar, S., et al., "Constitutive Expression of B7 Restores Immunogenicity of Tumor Cells Expressing Truncated Major Histocompatibility Complex Class II Molecules," Proc. Natl. Acad. Sci. USA, vol. 90, 5687-5690 (1993). |
Bateman, W.J., et al., "Inducibility of Class II Major Histocompatability Complex Antigens by Interferon .gamma. is Associated with Reduced Tumorigenicity in C3H Mouse Fibroblasts Transformed by v-Ki-ras," J. Exp. Med., vol. 173, 193-196 (1991). |
Chen, L., et al., "Costimulation of Antitumor Immunity by the B7 Counterreceptor for the T Lymphocyte Molecules CD28 and CTLA-4," Cell, vol. 71, 1093-1102 (1992). |
Clements, V., et al., "Invariant Chain Alters the Malignant Phenotype of MHC Class II.sup.+ Tumor Cells," The Journal of Immunology, vol. 149, No. 7, 2391-2396 (1992). |
Cole, G. and Ostrand-Rosenberg, S., "Rejection of Allogeneic Tumor is not Determined by Host Responses to MHC Class I Molecules and is Mediated by CD4.sup.- CD8.sup.+ T Lymphocytes that are not Lytic for the Tumor," Cellular Immunology, vol. 134, 480-490 (1991). |
Fearon, E., et al., "Interleukin-2 Production by Tumor Cells Bypasses T Helper Function in the Generation of an Antitumor Response," Cell, vol. 60, 397-403 (1990). |
Freedman, A., et al., "B7, a B Cell-Restricted Antigen that Identifies Preactivated B Cells," J. Immunology, vol. 139, 3260-3267 (1987). |
Schultz, K., et al., "The Role of B Cells for in Vivo T Cell Responses to a Friend Virus-Induced Leukemia," Science, vol. 249, 921-923 (1990). |
Tan, P., et al., "Induction of Alloantigen-specific Hyporesponsiveness in Human T Lymphocytes by Blocking Interaction of CD28 with its Natural Ligand B7/BB1," J. Exp. Med., vol. 177, 165-173 (1993). |
Thompson, C., et al., "CD28 Activation Pathway Regulates the Production of Multiple T-cell-derived Lymphokines/cytokines," Proc. Natl. Acad. Sci. USA, vol. 86, 1333-1337 (1989). |
Townsend, S. and Allison, J., "Expression of the T Cell Costimulatory Lignad B7 by a Melanoma Induces Rejection Mediated by Direct Activation of CD8.sup.+ T Cells," J. Cell. Biochem., Supplement, (Abstract NZ 627), 136 (1993). |
Townsend, S. and Allison, J., "Tumor Rejection After Direct Costimulatin of CD8.sup.+ T Cells by B7-Transfected Melanoma Cells," Science, vol. 259, 368-270 (1993). |
Van Der Bruggen, P., et al., "A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma," Science, vol. 254, 1643-1647 (1991). |